What Are Wall Street Analysts' Target Price for Cooper Companies’ Stock?

The Cooper Companies, Inc. (COO) is a global medical device company focused on vision care and women’s health. Through its CooperVision and CooperSurgical businesses, it develops products that support eye health and reproductive care. The company is headquartered in San Ramon, California, and serves healthcare professionals and patients around the world. It has a market capitalization of $12.20 billion.

Cooper Companies’ stock performance has been weak due to slower organic growth, especially in the contact lens business, and concerns about performance in the Asia-Pacific. Over the past 52 weeks, the stock has declined 21.1%, and it is down 23.7% year-to-date (YTD). COO’s shares reached a 52-week low of $58.89 on May 12, but are up 6.2% from that level.